L

Lipocine
D

LPCN

5.17000
USD
0.01
(0.19%)
Market Closed
Volume
87
EPS
-2
Div Yield
-
P/E
-7
Market Cap
27,648,850
OverviewSignalsIdeasNews
Related Instruments
    A
    ACST
    0
    (0%)
    0.000000 USD
    A
    AMRN
    -0.01500
    (-2.88%)
    0.50510 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    E
    EVOK
    0.06000
    (1.36%)
    4.46000 USD
    F
    FGEN
    -0.03530
    (-9.54%)
    0.33460 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Lipocine

Sector: Healthcare
Industry: Biotechnology
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.